Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
BirthGlide
Project | BirthGlide feasibility study |
---|---|
Description |
BirthGlide is developing a revolutionary device to prevent difficult birth in the pushing stage of labour and reduce the use of traumatic procedures such as forceps, vacuum or emergency C-sections. |
Funding | £ 99,836 |
Competition | Competition 25 - Women's health |
Competition Date | July 2024 |
Categories | Women's health |
Website | https://birthglide.com/ |
DDM Health Limited
Project | Supporting women with long-term and chronic health conditions with an adaptive, personalised digital health tool to self-manage and improve health outcomes ("GroW") |
---|---|
Description |
Gro Health is a multi-award-winning NICE-accredited digital health platform that supports individuals managing chronic conditions, including obesity and Type 2 diabetes. The platform provides personalised health pathways, data-driven insights, behavioral change tools and AI-driven engagement to enhance patient outcomes. The "GroW" project focuses on co-developing solutions with women living in social housing, a group considered hard to reach despite the greatest need for intervention. By understanding their unique needs, the project aims to adapt and personalise Gro Health to reduce health inequalities and deliver scalable, equitable, and impactful interventions for underserved communities - improving both individual and community health outcomes. |
Funding | £ 78,063 |
Competition | Competition 25 - Women's health |
Competition Date | July 2024 |
Categories | Women's health |
Website | https://www.ddm.health |
ScreenIn3D Limited
Project | An organ-on-a-chip platform to model personalised embryo implantation and improve subfertility associated with chronic gynaecological disease |
---|---|
Description |
Our technology uses engineering approaches to create cell-based models of human organs and disease, mimicking different aspects of human organ function. Using this approach, we have developed a technological platform to make testing of drug treatments more relevant to the individual. We can apply the technology to different human diseases, with a current focus on oncology, immune-oncology and women’s health, particularly in the areas of embryo implantation, and precision fertility. Overall, our technology offers technological solutions for producing better drugs, reduce reliance on animal models and accelerate the development of personalised treatments. |
Funding | £ 99,655 |
Competition | Competition 25 - Women's health |
Competition Date | July 2024 |
Categories | Women's health |
Website | https://screenin3d.com/ |